An animal model for assessing the potential antiparkinsonian characteristics of M4 muscarinic antagonists: Effects of the partially selective M4 antagonist tropicamide

被引：0
作者：
Salamone, JD [1 ]
Betz, AJ [1 ]
McLaughlin, PJ [1 ]
Burgos, M [1 ]
Ishiwari, K [1 ]
Weber, SM [1 ]
Felsted, J [1 ]
Brown, C [1 ]
机构：
[1] Univ Connecticut, Storrs, CT USA
来源：
BEHAVIOURAL PHARMACOLOGY | 2005年 / 16卷
关键词：
D O I：
10.1097/00008877-200509001-00220
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [21] DEVELOPMENT OF ANTISERA SELECTIVE FOR M4 AND M5 MUSCARINIC CHOLINERGIC RECEPTORS - DISTRIBUTION OF M4 AND M5 RECEPTORS IN RAT-BRAIN
    YASUDA, RP
    CIESLA, W
    FLORES, LR
    WALL, SJ
    LI, M
    SATKUS, SA
    WEISSTEIN, JS
    SPAGNOLA, BV
    WOLFE, BB
    MOLECULAR PHARMACOLOGY, 1993, 43 (02) : 149 - 157
  • [22] Involvement of a Subpopulation of Neuronal M4 Muscarinic Acetylcholine Receptors in the Antipsychotic-like Effects of the M1/M4 Preferring Muscarinic Receptor Agonist Xanomeline
    Dencker, Ditte
    Wortwein, Gitta
    Weikop, Pia
    Jeon, Jongrye
    Thomsen, Morgane
    Sager, Thomas N.
    Mork, Arne
    Woldbye, David P. D.
    Wess, Juergen
    Fink-Jensen, Anders
    JOURNAL OF NEUROSCIENCE, 2011, 31 (16) : 5905 - 5908
  • [23] M4 Muscarinic Receptors and Locomotor Activity Regulation
    Myslivecek, J.
    Farar, V.
    Valuskova, P.
    PHYSIOLOGICAL RESEARCH, 2017, 66 : S443 - S455
  • [24] Optimization and identification of brain penetrant, M4 subtype-selective muscarinic receptor positive allosteric modulator (M4 PAM) clinical candidate
    Butler, Christopher
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [25] Role of M1 and M4 receptors in development of myopia:: Study with muscarinic receptor antagonists and muscarinic toxins
    Diether, S
    Schaeffel, F
    Fritsch, C
    Trendelenburg, AU
    Payor, R
    Lambrou, GN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [26] Characterization of PD102807, a selective M4 muscarinic receptor antagonist:: Radioligand binding and functional studies
    Shetty, SG
    Bonhaus, D
    Loury, D
    Eglen, RM
    Hegde, SS
    Watson, N
    FASEB JOURNAL, 1998, 12 (04) : A141 - A141
  • [27] Development of Novel M4 Muscarinic Acetylcholine Receptor Antagonists for the Treatment of Movement Disorders
    Rook, Jerri
    Bender, Aaron
    Dickerson, Jonathan
    Foster, Daniel
    Rodriguez, Alice
    Niswender, Colleen
    Hess, Ellen
    Conn, Jeff
    Lindsley, Craig
    FASEB JOURNAL, 2022, 36
  • [28] Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor Antagonist
    Spock, Matthew
    Carter, Trever R.
    Bollinger, Katrina A.
    Han, Changho
    Baker, Logan A.
    Rodriguez, Alice L.
    Peng, Li
    Dickerson, Jonathan W.
    Qi, Aidong
    Rook, Jerri M.
    O'Neill, Jordan C.
    Watson, Katherine J.
    Chang, Sichen
    Bridges, Thomas M.
    Engers, Julie L.
    Engers, Darren W.
    Niswender, Colleen M.
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Bender, Aaron M.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (08): : 1342 - 1349
  • [29] Identification of rat brain muscarinic M4 receptors coupled to cyclic AMP using the selective antagonist muscarinic toxin 3
    Olianas, MC
    Adem, A
    Karlsson, E
    Onali, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 357 (2-3) : 235 - 242
  • [30] Effects of Selective Activation of M1 and M4 Muscarinic Receptors on Object Recognition Memory Performance in Rats
    Galloway, Claire R.
    Lebois, Evan P.
    Shagarabi, Shezza L.
    Hernandez, Norma A.
    Manns, Joseph R.
    PHARMACOLOGY, 2014, 93 (1-2) : 57 - 64
12345